Fatal Anaphylaxis in the Presence of Eosinophilic Pneumonia in an Asthmatic Patient. A Case Report

Man Liang,Ananda Sunnassee,Liu Yan,Na Zheng,Luo Zhuo,Zhang Haidong,Liu Liang
DOI: https://doi.org/10.4323/rjlm.2010.193
2010-01-01
Romanian Journal of Legal Medicine
Abstract:Eosinophilic pneumonia (EP) is a rare allergic syndrome. It has been subdivided into two types including acute eosinophilic pneumonia and chronic eosinophilic pneumonia. The pathology of EP is usually characterized by diffuse eosinophilic granulocyte infiltration in the lungs. We present the unusual case of a 39-year-old woman who died unexpectedly in hospital. She had a previous history of asthma and repeated hospital admissions. A fatal asthmatic attack was initially opined as the cause of death but autopsy disclosed that she died of anaphylactic shock in the presence of EP. Microscopic examination of organs and tissues showed eosinophilic granulocyte infiltration not only in the lungs, but also in the splenic sinuses, gastric mucosa and at the injection site on the skin of the dorsum of the hand. Patients with EP very rarely show eosinophilic granulocytes infiltration in locations other than the lungs. Her hypersensitive diasthesis, injection infusion of a combination of a traditional Chinese drug and western drug and the presence of EP were together contributed to anaphylaxis and death. osinophilic pneumonia (EP) is an allergic syndrome classified as either 'acute eosinophilic pneumonia' (AEP) or 'chronic eosinophilic pneumonia' (CEP) depending on the symptoms a person is experiencing. The majority of patients affected are middle- aged females, especially those with a hypersensitive diathesis. The incidence of AEP is estimated to be 9.1 per 100,000 person-years (95% confidence interval, 4.3-13.3), and death in these cases is usually due to respiratory failure (1). Few individuals die of CEP (2). Although a few clinical and epidemiological studies have been carried out (3), case reports and research articles concerning EP in forensic medicine are scarce. Patients with EP usually have a hypersensitive diathesis and they are more prone to anaphylaxis. We present this unusual case of unexpected death due to anaphylactic shock in the presence of EP after intravenous infusion of drugs regimen. Case report A 39-year-old Chinese woman who had a previous history of bronchial asthma, experienced dyspnea and tachypnea she was rushed and to a clinic found in her vicinity. Two weeks prior to this episode, she had been taking some cephalosporin antibiotic, aminophylline and a compound traditional Chinese medication called 'Shuanhuanglian', but she was not relieved.
What problem does this paper attempt to address?